EP2425820
Aðferðarfræði við meðferð með díhýdróergótamíni til að lina mígreni fljótt jafnframt því að lágmarka aukaverkanir
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
11.2.2008EP published:
8.4.2015EP application number:
11191794.4
EP translation filed:
6.5.2015Grant published:
15.6.2015EPO information:
European Patent Register
Max expiry date:
10.2.2028Expiry date:
10.2.2025
Title:
Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
Timeline
Today
11.2.2008EP application
8.4.2015EP Publication
6.5.2015Translation submitted
15.6.2015Registration published
10.2.2025Expires
Owner
Name:
MAP Pharmaceuticals IncAddress:
2525 Dupont Drive, 92612, Irvine, CA, US
Inventor
Name:
Cook, Robert, O.Address:
New Jersey,, US
Name:
Shrewsbury, Stephen, B.Address:
Cupertino, CA, US
Name:
Ramadan, NabihAddress:
Lake Forest IL,, US
Name:
Armer, Thomas, A.Address:
Mountain View CA,, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
900850 PDate:
11.2.2007Country:
US
Classification
Categories:
A61K 9/12, A61K 31/48, A61K 9/72, A61P 25/06
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 20.1.2016
Expires: 10.2.2017
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 18.1.2017
Expires: 10.2.2018
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.1.2018
Expires: 10.2.2019
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.1.2019
Expires: 10.2.2020
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 20.1.2020
Expires: 10.2.2021
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 19.1.2021
Expires: 10.2.2022
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 19.1.2022
Expires: 10.2.2023
Payer: Árnason Faktor ehf.
Number: 16
Paid: 12.1.2023
Expires: 10.2.2024
Payer: Árnason Faktor ehf.
Number: 17
Paid: 10.1.2024
Expires: 10.2.2025
Payer: Árnason Faktor ehf.